Global Solid-phase Oligonucleotide Synthesis Market Growth (Status and Outlook) 2022-2028
As the global economy mends, the 2021 growth of Solid-phase Oligonucleotide Synthesis will have significant change from previous year. According to our (LP Information) latest study, the global Solid-phase Oligonucleotide Synthesis market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Solid-phase Oligonucleotide Synthesis market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.
The United States Solid-phase Oligonucleotide Synthesis market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Solid-phase Oligonucleotide Synthesis market, reaching US$ million by the year 2028. As for the Europe Solid-phase Oligonucleotide Synthesis landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Solid-phase Oligonucleotide Synthesis players cover Genescript, GeneArt (Thermofischer), Renesas Electronics Corporation, and DNA 2.0 (ATUM), etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Solid-phase Oligonucleotide Synthesis market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Primers
Probes
Intermediate-scale Synthesis Oligos
Large-scale Synthesis Oligos
Linkers and Adaptors
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Commercial
Academic Research
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Genescript
GeneArt (Thermofischer)
Renesas Electronics Corporation
DNA 2.0 (ATUM)
OriGene
BBI
Genewiz
Eurofins Genomics
Gene Oracle
SBS Genetech
Bio Basic
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Solid-phase Oligonucleotide Synthesis Market Size 2017-2028
2.1.2 Solid-phase Oligonucleotide Synthesis Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Solid-phase Oligonucleotide Synthesis Segment by Type
2.2.1 Primers
2.2.2 Probes
2.2.3 Intermediate-scale Synthesis Oligos
2.2.4 Large-scale Synthesis Oligos
2.2.5 Linkers and Adaptors
2.3 Solid-phase Oligonucleotide Synthesis Market Size by Type
2.3.1 Solid-phase Oligonucleotide Synthesis Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Solid-phase Oligonucleotide Synthesis Market Size Market Share by Type (2017-2022)
2.4 Solid-phase Oligonucleotide Synthesis Segment by Application
2.4.1 Commercial
2.4.2 Academic Research
2.5 Solid-phase Oligonucleotide Synthesis Market Size by Application
2.5.1 Solid-phase Oligonucleotide Synthesis Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Solid-phase Oligonucleotide Synthesis Market Size Market Share by Application (2017-2022)
3 Solid-phase Oligonucleotide Synthesis Market Size by Player
3.1 Solid-phase Oligonucleotide Synthesis Market Size Market Share by Players
3.1.1 Global Solid-phase Oligonucleotide Synthesis Revenue by Players (2020-2022)
3.1.2 Global Solid-phase Oligonucleotide Synthesis Revenue Market Share by Players (2020-2022)
3.2 Global Solid-phase Oligonucleotide Synthesis Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Solid-phase Oligonucleotide Synthesis by Regions
4.1 Solid-phase Oligonucleotide Synthesis Market Size by Regions (2017-2022)
4.2 Americas Solid-phase Oligonucleotide Synthesis Market Size Growth (2017-2022)
4.3 APAC Solid-phase Oligonucleotide Synthesis Market Size Growth (2017-2022)
4.4 Europe Solid-phase Oligonucleotide Synthesis Market Size Growth (2017-2022)
4.5 Middle East & Africa Solid-phase Oligonucleotide Synthesis Market Size Growth (2017-2022)
5 Americas
5.1 Americas Solid-phase Oligonucleotide Synthesis Market Size by Country (2017-2022)
5.2 Americas Solid-phase Oligonucleotide Synthesis Market Size by Type (2017-2022)
5.3 Americas Solid-phase Oligonucleotide Synthesis Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Solid-phase Oligonucleotide Synthesis Market Size by Region (2017-2022)
6.2 APAC Solid-phase Oligonucleotide Synthesis Market Size by Type (2017-2022)
6.3 APAC Solid-phase Oligonucleotide Synthesis Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Solid-phase Oligonucleotide Synthesis by Country (2017-2022)
7.2 Europe Solid-phase Oligonucleotide Synthesis Market Size by Type (2017-2022)
7.3 Europe Solid-phase Oligonucleotide Synthesis Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Solid-phase Oligonucleotide Synthesis by Region (2017-2022)
8.2 Middle East & Africa Solid-phase Oligonucleotide Synthesis Market Size by Type (2017-2022)
8.3 Middle East & Africa Solid-phase Oligonucleotide Synthesis Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Solid-phase Oligonucleotide Synthesis Market Forecast
10.1 Global Solid-phase Oligonucleotide Synthesis Forecast by Regions (2023-2028)
10.1.1 Global Solid-phase Oligonucleotide Synthesis Forecast by Regions (2023-2028)
10.1.2 Americas Solid-phase Oligonucleotide Synthesis Forecast
10.1.3 APAC Solid-phase Oligonucleotide Synthesis Forecast
10.1.4 Europe Solid-phase Oligonucleotide Synthesis Forecast
10.1.5 Middle East & Africa Solid-phase Oligonucleotide Synthesis Forecast
10.2 Americas Solid-phase Oligonucleotide Synthesis Forecast by Country (2023-2028)
10.2.1 United States Solid-phase Oligonucleotide Synthesis Market Forecast
10.2.2 Canada Solid-phase Oligonucleotide Synthesis Market Forecast
10.2.3 Mexico Solid-phase Oligonucleotide Synthesis Market Forecast
10.2.4 Brazil Solid-phase Oligonucleotide Synthesis Market Forecast
10.3 APAC Solid-phase Oligonucleotide Synthesis Forecast by Region (2023-2028)
10.3.1 China Solid-phase Oligonucleotide Synthesis Market Forecast
10.3.2 Japan Solid-phase Oligonucleotide Synthesis Market Forecast
10.3.3 Korea Solid-phase Oligonucleotide Synthesis Market Forecast
10.3.4 Southeast Asia Solid-phase Oligonucleotide Synthesis Market Forecast
10.3.5 India Solid-phase Oligonucleotide Synthesis Market Forecast
10.3.6 Australia Solid-phase Oligonucleotide Synthesis Market Forecast
10.4 Europe Solid-phase Oligonucleotide Synthesis Forecast by Country (2023-2028)
10.4.1 Germany Solid-phase Oligonucleotide Synthesis Market Forecast
10.4.2 France Solid-phase Oligonucleotide Synthesis Market Forecast
10.4.3 UK Solid-phase Oligonucleotide Synthesis Market Forecast
10.4.4 Italy Solid-phase Oligonucleotide Synthesis Market Forecast
10.4.5 Russia Solid-phase Oligonucleotide Synthesis Market Forecast
10.5 Middle East & Africa Solid-phase Oligonucleotide Synthesis Forecast by Region (2023-2028)
10.5.1 Egypt Solid-phase Oligonucleotide Synthesis Market Forecast
10.5.2 South Africa Solid-phase Oligonucleotide Synthesis Market Forecast
10.5.3 Israel Solid-phase Oligonucleotide Synthesis Market Forecast
10.5.4 Turkey Solid-phase Oligonucleotide Synthesis Market Forecast
10.5.5 GCC Countries Solid-phase Oligonucleotide Synthesis Market Forecast
10.6 Global Solid-phase Oligonucleotide Synthesis Forecast by Type (2023-2028)
10.7 Global Solid-phase Oligonucleotide Synthesis Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Genescript
11.1.1 Genescript Company Information
11.1.2 Genescript Solid-phase Oligonucleotide Synthesis Product Offered
11.1.3 Genescript Solid-phase Oligonucleotide Synthesis Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Genescript Main Business Overview
11.1.5 Genescript Latest Developments
11.2 GeneArt (Thermofischer)
11.2.1 GeneArt (Thermofischer) Company Information
11.2.2 GeneArt (Thermofischer) Solid-phase Oligonucleotide Synthesis Product Offered
11.2.3 GeneArt (Thermofischer) Solid-phase Oligonucleotide Synthesis Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 GeneArt (Thermofischer) Main Business Overview
11.2.5 GeneArt (Thermofischer) Latest Developments
11.3 Renesas Electronics Corporation
11.3.1 Renesas Electronics Corporation Company Information
11.3.2 Renesas Electronics Corporation Solid-phase Oligonucleotide Synthesis Product Offered
11.3.3 Renesas Electronics Corporation Solid-phase Oligonucleotide Synthesis Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Renesas Electronics Corporation Main Business Overview
11.3.5 Renesas Electronics Corporation Latest Developments
11.4 DNA 2.0 (ATUM)
11.4.1 DNA 2.0 (ATUM) Company Information
11.4.2 DNA 2.0 (ATUM) Solid-phase Oligonucleotide Synthesis Product Offered
11.4.3 DNA 2.0 (ATUM) Solid-phase Oligonucleotide Synthesis Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 DNA 2.0 (ATUM) Main Business Overview
11.4.5 DNA 2.0 (ATUM) Latest Developments
11.5 OriGene
11.5.1 OriGene Company Information
11.5.2 OriGene Solid-phase Oligonucleotide Synthesis Product Offered
11.5.3 OriGene Solid-phase Oligonucleotide Synthesis Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 OriGene Main Business Overview
11.5.5 OriGene Latest Developments
11.6 BBI
11.6.1 BBI Company Information
11.6.2 BBI Solid-phase Oligonucleotide Synthesis Product Offered
11.6.3 BBI Solid-phase Oligonucleotide Synthesis Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 BBI Main Business Overview
11.6.5 BBI Latest Developments
11.7 Genewiz
11.7.1 Genewiz Company Information
11.7.2 Genewiz Solid-phase Oligonucleotide Synthesis Product Offered
11.7.3 Genewiz Solid-phase Oligonucleotide Synthesis Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Genewiz Main Business Overview
11.7.5 Genewiz Latest Developments
11.8 Eurofins Genomics
11.8.1 Eurofins Genomics Company Information
11.8.2 Eurofins Genomics Solid-phase Oligonucleotide Synthesis Product Offered
11.8.3 Eurofins Genomics Solid-phase Oligonucleotide Synthesis Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Eurofins Genomics Main Business Overview
11.8.5 Eurofins Genomics Latest Developments
11.9 Gene Oracle
11.9.1 Gene Oracle Company Information
11.9.2 Gene Oracle Solid-phase Oligonucleotide Synthesis Product Offered
11.9.3 Gene Oracle Solid-phase Oligonucleotide Synthesis Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Gene Oracle Main Business Overview
11.9.5 Gene Oracle Latest Developments
11.10 SBS Genetech
11.10.1 SBS Genetech Company Information
11.10.2 SBS Genetech Solid-phase Oligonucleotide Synthesis Product Offered
11.10.3 SBS Genetech Solid-phase Oligonucleotide Synthesis Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 SBS Genetech Main Business Overview
11.10.5 SBS Genetech Latest Developments
11.11 Bio Basic
11.11.1 Bio Basic Company Information
11.11.2 Bio Basic Solid-phase Oligonucleotide Synthesis Product Offered
11.11.3 Bio Basic Solid-phase Oligonucleotide Synthesis Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Bio Basic Main Business Overview
11.11.5 Bio Basic Latest Developments
12 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Solid-phase Oligonucleotide Synthesis Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Primers
Table 3. Major Players of Probes
Table 4. Major Players of Intermediate-scale Synthesis Oligos
Table 5. Major Players of Large-scale Synthesis Oligos
Table 6. Major Players of Linkers and Adaptors
Table 7. Solid-phase Oligonucleotide Synthesis Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Solid-phase Oligonucleotide Synthesis Market Size by Type (2017-2022) & ($ Millions)
Table 9. Global Solid-phase Oligonucleotide Synthesis Market Size Market Share by Type (2017-2022)
Table 10. Solid-phase Oligonucleotide Synthesis Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 11. Global Solid-phase Oligonucleotide Synthesis Market Size by Application (2017-2022) & ($ Millions)
Table 12. Global Solid-phase Oligonucleotide Synthesis Market Size Market Share by Application (2017-2022)
Table 13. Global Solid-phase Oligonucleotide Synthesis Revenue by Players (2020-2022) & ($ Millions)
Table 14. Global Solid-phase Oligonucleotide Synthesis Revenue Market Share by Player (2020-2022)
Table 15. Solid-phase Oligonucleotide Synthesis Key Players Head office and Products Offered
Table 16. Solid-phase Oligonucleotide Synthesis Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Solid-phase Oligonucleotide Synthesis Market Size by Regions 2017-2022 & ($ Millions)
Table 20. Global Solid-phase Oligonucleotide Synthesis Market Size Market Share by Regions (2017-2022)
Table 21. Americas Solid-phase Oligonucleotide Synthesis Market Size by Country (2017-2022) & ($ Millions)
Table 22. Americas Solid-phase Oligonucleotide Synthesis Market Size Market Share by Country (2017-2022)
Table 23. Americas Solid-phase Oligonucleotide Synthesis Market Size by Type (2017-2022) & ($ Millions)
Table 24. Americas Solid-phase Oligonucleotide Synthesis Market Size Market Share by Type (2017-2022)
Table 25. Americas Solid-phase Oligonucleotide Synthesis Market Size by Application (2017-2022) & ($ Millions)
Table 26. Americas Solid-phase Oligonucleotide Synthesis Market Size Market Share by Application (2017-2022)
Table 27. APAC Solid-phase Oligonucleotide Synthesis Market Size by Region (2017-2022) & ($ Millions)
Table 28. APAC Solid-phase Oligonucleotide Synthesis Market Size Market Share by Region (2017-2022)
Table 29. APAC Solid-phase Oligonucleotide Synthesis Market Size by Type (2017-2022) & ($ Millions)
Table 30. APAC Solid-phase Oligonucleotide Synthesis Market Size Market Share by Type (2017-2022)
Table 31. APAC Solid-phase Oligonucleotide Synthesis Market Size by Application (2017-2022) & ($ Millions)
Table 32. APAC Solid-phase Oligonucleotide Synthesis Market Size Market Share by Application (2017-2022)
Table 33. Europe Solid-phase Oligonucleotide Synthesis Market Size by Country (2017-2022) & ($ Millions)
Table 34. Europe Solid-phase Oligonucleotide Synthesis Market Size Market Share by Country (2017-2022)
Table 35. Europe Solid-phase Oligonucleotide Synthesis Market Size by Type (2017-2022) & ($ Millions)
Table 36. Europe Solid-phase Oligonucleotide Synthesis Market Size Market Share by Type (2017-2022)
Table 37. Europe Solid-phase Oligonucleotide Synthesis Market Size by Application (2017-2022) & ($ Millions)
Table 38. Europe Solid-phase Oligonucleotide Synthesis Market Size Market Share by Application (2017-2022)
Table 39. Middle East & Africa Solid-phase Oligonucleotide Synthesis Market Size by Region (2017-2022) & ($ Millions)
Table 40. Middle East & Africa Solid-phase Oligonucleotide Synthesis Market Size Market Share by Region (2017-2022)
Table 41. Middle East & Africa Solid-phase Oligonucleotide Synthesis Market Size by Type (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Solid-phase Oligonucleotide Synthesis Market Size Market Share by Type (2017-2022)
Table 43. Middle East & Africa Solid-phase Oligonucleotide Synthesis Market Size by Application (2017-2022) & ($ Millions)
Table 44. Middle East & Africa Solid-phase Oligonucleotide Synthesis Market Size Market Share by Application (2017-2022)
Table 45. Key Market Drivers & Growth Opportunities of Solid-phase Oligonucleotide Synthesis
Table 46. Key Market Challenges & Risks of Solid-phase Oligonucleotide Synthesis
Table 47. Key Industry Trends of Solid-phase Oligonucleotide Synthesis
Table 48. Global Solid-phase Oligonucleotide Synthesis Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 49. Global Solid-phase Oligonucleotide Synthesis Market Size Market Share Forecast by Regions (2023-2028)
Table 50. Global Solid-phase Oligonucleotide Synthesis Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 51. Global Solid-phase Oligonucleotide Synthesis Market Size Market Share Forecast by Type (2023-2028)
Table 52. Global Solid-phase Oligonucleotide Synthesis Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 53. Global Solid-phase Oligonucleotide Synthesis Market Size Market Share Forecast by Application (2023-2028)
Table 54. Genescript Details, Company Type, Solid-phase Oligonucleotide Synthesis Area Served and Its Competitors
Table 55. Genescript Solid-phase Oligonucleotide Synthesis Product Offered
Table 56. Genescript Solid-phase Oligonucleotide Synthesis Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 57. Genescript Main Business
Table 58. Genescript Latest Developments
Table 59. GeneArt (Thermofischer) Details, Company Type, Solid-phase Oligonucleotide Synthesis Area Served and Its Competitors
Table 60. GeneArt (Thermofischer) Solid-phase Oligonucleotide Synthesis Product Offered
Table 61. GeneArt (Thermofischer) Main Business
Table 62. GeneArt (Thermofischer) Solid-phase Oligonucleotide Synthesis Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 63. GeneArt (Thermofischer) Latest Developments
Table 64. Renesas Electronics Corporation Details, Company Type, Solid-phase Oligonucleotide Synthesis Area Served and Its Competitors
Table 65. Renesas Electronics Corporation Solid-phase Oligonucleotide Synthesis Product Offered
Table 66. Renesas Electronics Corporation Main Business
Table 67. Renesas Electronics Corporation Solid-phase Oligonucleotide Synthesis Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 68. Renesas Electronics Corporation Latest Developments
Table 69. DNA 2.0 (ATUM) Details, Company Type, Solid-phase Oligonucleotide Synthesis Area Served and Its Competitors
Table 70. DNA 2.0 (ATUM) Solid-phase Oligonucleotide Synthesis Product Offered
Table 71. DNA 2.0 (ATUM) Main Business
Table 72. DNA 2.0 (ATUM) Solid-phase Oligonucleotide Synthesis Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 73. DNA 2.0 (ATUM) Latest Developments
Table 74. OriGene Details, Company Type, Solid-phase Oligonucleotide Synthesis Area Served and Its Competitors
Table 75. OriGene Solid-phase Oligonucleotide Synthesis Product Offered
Table 76. OriGene Main Business
Table 77. OriGene Solid-phase Oligonucleotide Synthesis Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 78. OriGene Latest Developments
Table 79. BBI Details, Company Type, Solid-phase Oligonucleotide Synthesis Area Served and Its Competitors
Table 80. BBI Solid-phase Oligonucleotide Synthesis Product Offered
Table 81. BBI Main Business
Table 82. BBI Solid-phase Oligonucleotide Synthesis Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 83. BBI Latest Developments
Table 84. Genewiz Details, Company Type, Solid-phase Oligonucleotide Synthesis Area Served and Its Competitors
Table 85. Genewiz Solid-phase Oligonucleotide Synthesis Product Offered
Table 86. Genewiz Main Business
Table 87. Genewiz Solid-phase Oligonucleotide Synthesis Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 88. Genewiz Latest Developments
Table 89. Eurofins Genomics Details, Company Type, Solid-phase Oligonucleotide Synthesis Area Served and Its Competitors
Table 90. Eurofins Genomics Solid-phase Oligonucleotide Synthesis Product Offered
Table 91. Eurofins Genomics Main Business
Table 92. Eurofins Genomics Solid-phase Oligonucleotide Synthesis Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 93. Eurofins Genomics Latest Developments
Table 94. Gene Oracle Details, Company Type, Solid-phase Oligonucleotide Synthesis Area Served and Its Competitors
Table 95. Gene Oracle Solid-phase Oligonucleotide Synthesis Product Offered
Table 96. Gene Oracle Main Business
Table 97. Gene Oracle Solid-phase Oligonucleotide Synthesis Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 98. Gene Oracle Latest Developments
Table 99. SBS Genetech Details, Company Type, Solid-phase Oligonucleotide Synthesis Area Served and Its Competitors
Table 100. SBS Genetech Solid-phase Oligonucleotide Synthesis Product Offered
Table 101. SBS Genetech Main Business
Table 102. SBS Genetech Solid-phase Oligonucleotide Synthesis Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 103. SBS Genetech Latest Developments
Table 104. Bio Basic Details, Company Type, Solid-phase Oligonucleotide Synthesis Area Served and Its Competitors
Table 105. Bio Basic Solid-phase Oligonucleotide Synthesis Product Offered
Table 106. Bio Basic Solid-phase Oligonucleotide Synthesis Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 107. Bio Basic Main Business
Table 108. Bio Basic Latest Developments
List of Figures
Figure 1. Solid-phase Oligonucleotide Synthesis Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Solid-phase Oligonucleotide Synthesis Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Solid-phase Oligonucleotide Synthesis Market Size Market Share by Type in 2021
Figure 7. Solid-phase Oligonucleotide Synthesis in Commercial
Figure 8. Global Solid-phase Oligonucleotide Synthesis Market: Commercial (2017-2022) & ($ Millions)
Figure 9. Solid-phase Oligonucleotide Synthesis in Academic Research
Figure 10. Global Solid-phase Oligonucleotide Synthesis Market: Academic Research (2017-2022) & ($ Millions)
Figure 11. Global Solid-phase Oligonucleotide Synthesis Market Size Market Share by Application in 2021
Figure 12. Global Solid-phase Oligonucleotide Synthesis Revenue Market Share by Player in 2021
Figure 13. Global Solid-phase Oligonucleotide Synthesis Market Size Market Share by Regions (2017-2022)
Figure 14. Americas Solid-phase Oligonucleotide Synthesis Market Size 2017-2022 ($ Millions)
Figure 15. APAC Solid-phase Oligonucleotide Synthesis Market Size 2017-2022 ($ Millions)
Figure 16. Europe Solid-phase Oligonucleotide Synthesis Market Size 2017-2022 ($ Millions)
Figure 17. Middle East & Africa Solid-phase Oligonucleotide Synthesis Market Size 2017-2022 ($ Millions)
Figure 18. Americas Solid-phase Oligonucleotide Synthesis Value Market Share by Country in 2021
Figure 19. Americas Solid-phase Oligonucleotide Synthesis Consumption Market Share by Type in 2021
Figure 20. Americas Solid-phase Oligonucleotide Synthesis Market Size Market Share by Application in 2021
Figure 21. United States Solid-phase Oligonucleotide Synthesis Market Size Growth 2017-2022 ($ Millions)
Figure 22. Canada Solid-phase Oligonucleotide Synthesis Market Size Growth 2017-2022 ($ Millions)
Figure 23. Mexico Solid-phase Oligonucleotide Synthesis Market Size Growth 2017-2022 ($ Millions)
Figure 24. Brazil Solid-phase Oligonucleotide Synthesis Market Size Growth 2017-2022 ($ Millions)
Figure 25. APAC Solid-phase Oligonucleotide Synthesis Market Size Market Share by Region in 2021
Figure 26. APAC Solid-phase Oligonucleotide Synthesis Market Size Market Share by Application in 2021
Figure 27. China Solid-phase Oligonucleotide Synthesis Market Size Growth 2017-2022 ($ Millions)
Figure 28. Japan Solid-phase Oligonucleotide Synthesis Market Size Growth 2017-2022 ($ Millions)
Figure 29. Korea Solid-phase Oligonucleotide Synthesis Market Size Growth 2017-2022 ($ Millions)
Figure 30. Southeast Asia Solid-phase Oligonucleotide Synthesis Market Size Growth 2017-2022 ($ Millions)
Figure 31. India Solid-phase Oligonucleotide Synthesis Market Size Growth 2017-2022 ($ Millions)
Figure 32. Australia Solid-phase Oligonucleotide Synthesis Market Size Growth 2017-2022 ($ Millions)
Figure 33. Europe Solid-phase Oligonucleotide Synthesis Market Size Market Share by Country in 2021
Figure 34. Europe Solid-phase Oligonucleotide Synthesis Market Size Market Share by Type in 2021
Figure 35. Europe Solid-phase Oligonucleotide Synthesis Market Size Market Share by Application in 2021
Figure 36. Germany Solid-phase Oligonucleotide Synthesis Market Size Growth 2017-2022 ($ Millions)
Figure 37. France Solid-phase Oligonucleotide Synthesis Market Size Growth 2017-2022 ($ Millions)
Figure 38. UK Solid-phase Oligonucleotide Synthesis Market Size Growth 2017-2022 ($ Millions)
Figure 39. Italy Solid-phase Oligonucleotide Synthesis Market Size Growth 2017-2022 ($ Millions)
Figure 40. Russia Solid-phase Oligonucleotide Synthesis Market Size Growth 2017-2022 ($ Millions)
Figure 41. Middle East & Africa Solid-phase Oligonucleotide Synthesis Market Size Market Share by Region in 2021
Figure 42. Middle East & Africa Solid-phase Oligonucleotide Synthesis Market Size Market Share by Type in 2021
Figure 43. Middle East & Africa Solid-phase Oligonucleotide Synthesis Market Size Market Share by Application in 2021
Figure 44. Egypt Solid-phase Oligonucleotide Synthesis Market Size Growth 2017-2022 ($ Millions)
Figure 45. South Africa Solid-phase Oligonucleotide Synthesis Market Size Growth 2017-2022 ($ Millions)
Figure 46. Israel Solid-phase Oligonucleotide Synthesis Market Size Growth 2017-2022 ($ Millions)
Figure 47. Turkey Solid-phase Oligonucleotide Synthesis Market Size Growth 2017-2022 ($ Millions)
Figure 48. GCC Country Solid-phase Oligonucleotide Synthesis Market Size Growth 2017-2022 ($ Millions)
Figure 49. Americas Solid-phase Oligonucleotide Synthesis Market Size 2023-2028 ($ Millions)
Figure 50. APAC Solid-phase Oligonucleotide Synthesis Market Size 2023-2028 ($ Millions)
Figure 51. Europe Solid-phase Oligonucleotide Synthesis Market Size 2023-2028 ($ Millions)
Figure 52. Middle East & Africa Solid-phase Oligonucleotide Synthesis Market Size 2023-2028 ($ Millions)
Figure 53. United States Solid-phase Oligonucleotide Synthesis Market Size 2023-2028 ($ Millions)
Figure 54. Canada Solid-phase Oligonucleotide Synthesis Market Size 2023-2028 ($ Millions)
Figure 55. Mexico Solid-phase Oligonucleotide Synthesis Market Size 2023-2028 ($ Millions)
Figure 56. Brazil Solid-phase Oligonucleotide Synthesis Market Size 2023-2028 ($ Millions)
Figure 57. China Solid-phase Oligonucleotide Synthesis Market Size 2023-2028 ($ Millions)
Figure 58. Japan Solid-phase Oligonucleotide Synthesis Market Size 2023-2028 ($ Millions)
Figure 59. Korea Solid-phase Oligonucleotide Synthesis Market Size 2023-2028 ($ Millions)
Figure 60. Southeast Asia Solid-phase Oligonucleotide Synthesis Market Size 2023-2028 ($ Millions)
Figure 61. India Solid-phase Oligonucleotide Synthesis Market Size 2023-2028 ($ Millions)
Figure 62. Australia Solid-phase Oligonucleotide Synthesis Market Size 2023-2028 ($ Millions)
Figure 63. Germany Solid-phase Oligonucleotide Synthesis Market Size 2023-2028 ($ Millions)
Figure 64. France Solid-phase Oligonucleotide Synthesis Market Size 2023-2028 ($ Millions)
Figure 65. UK Solid-phase Oligonucleotide Synthesis Market Size 2023-2028 ($ Millions)
Figure 66. Italy Solid-phase Oligonucleotide Synthesis Market Size 2023-2028 ($ Millions)
Figure 67. Russia Solid-phase Oligonucleotide Synthesis Market Size 2023-2028 ($ Millions)
Figure 68. Spain Solid-phase Oligonucleotide Synthesis Market Size 2023-2028 ($ Millions)
Figure 69. Egypt Solid-phase Oligonucleotide Synthesis Market Size 2023-2028 ($ Millions)
Figure 70. South Africa Solid-phase Oligonucleotide Synthesis Market Size 2023-2028 ($ Millions)
Figure 71. Israel Solid-phase Oligonucleotide Synthesis Market Size 2023-2028 ($ Millions)
Figure 72. Turkey Solid-phase Oligonucleotide Synthesis Market Size 2023-2028 ($ Millions)
Figure 73. GCC Countries Solid-phase Oligonucleotide Synthesis Market Size 2023-2028 ($ Millions)
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets